- Limitations of Global Pharmaceutical Companies' Development of New Drugs
-
- Although there were successful cases in preclinical trials using mice, more than 85% failed in early clinical trials.
- Waste of mice in preclinical trials.
- Lack of experimental animals due to medium-to-large sized preclinical trials.
- A Dog as Disease Model Animal
-
- A relatively longer life expectancy compared to mice.
- Share similar biological mechanisms with humans and
have the same genetic diseases. - Dogs and cats are the only animals with Alzheimer’s
Disease and Parkinson’s Disease - Command and behavior control are possible, therefore,
cognitive/motor ability analysis and
evaluation are possible for brain function evaluation.
- Alzheimer's disease is the most common degenerative neurological disease that causes dementia and deteriorates memory and cognitive function. Using genetic scissors technology and somatic cell nuclear transplantation technology, disease model animals can be developed, and through this, it can be used for research on pathogenesis and new drug development.
In Parkinson’s disease, the abnormal functioning of a neurotransmitter in the brain, ‘dopamine’, causes slow movement, tremors, and stiff muscles which cause physical disabilities. In animals, it is only identified in dogs and cats
- Confirmation of dopamine secretion
abnormalities through PET-CT scans. -
-
Normal Dog
-
Parkinson’s Disease
Model Cloned Animal
-
In Parkinson’s disease, the abnormal functioning of a neurotransmitter in the brain, ‘dopamine’, causes slow movement, tremors, and stiff muscles which cause physical disabilities. In animals, it is only identified in dogs and cats
- Confirmation of dopamine secretion abnormalities through PET-CT scans.
-
-
Normal Dog
-
Parkinson’s Disease Model Cloned Animal
-
BEFORE
We will advance the development of new drugs by developing
a customized disease model to treat human diseases.
AFTER
a customized disease model to treat human diseases.
AFTER
We will advance the development of new drugs by developing a customized disease model to treat human diseases.